Outlook Therapeutics, Inc. (OTLK) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time OTLK price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 46.6 Neutral
Market Cap $134.2M
Volume 6.4M
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-27.5M
EPS $-0.39
P/E Ratio -2.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Sukhtian Faisal Ghiath | Director | Buy | 95,398 | $1.05 | $99,996 | 2026 Jul 29 |
| Haddadin Yezan Munther | Director | Buy | 29,000 | $0.83 | $24,145 | 2026 Jun 2 |
| Sukhtian Ghiath M. | Insider | Buy | 8,539,709 | $0.59 | $5.0M | 2026 May 28 |
| Sukhtian Faisal Ghiath | Director | Buy | 122,174 | $0.41 | $50,006 | 2026 May 27 |
| Haddadin Yezan Munther | Director | Buy | 34,000 | $0.44 | $14,960 | 2026 May 26 |
| Thurman Randy H | Director | Buy | 5,000 | $0.43 | $2,145 | 2026 May 26 |
| Hilzinger Kurt J | Director | Buy | 400,000 | $0.44 | $176,520 | 2026 May 26 |
| Kenyon Lawrence A | Chief Financial Officer | Buy | 5,000 | $5.69 | $28,450 | 2024 Sep 26 |
| Syntone Ventures LLC | 10% Owner | Buy | 714,286 | $0.00 | $0 | 2024 Apr 15 |
| Haddadin Yezan Munther | Director | Buy | 1,882 | $11.82 | $22,242 | 2024 Mar 28 |
| Evanson Jeff | CHIEF COMMERCIAL OFFICER | Buy | 62,484 | $0.42 | $26,243 | 2024 Mar 7 |
| Dagnon Terry | Chief Operations Officer | Sell | 520,000 | $1.14 | $592,800 | 2023 Apr 20 |
| Evanson Jeff | Chief Commercial Officer | Sell | 267,000 | $1.11 | $296,370 | 2023 Jan 20 |
| Evanson Jeff | Chief Commercial Officer | Sell | 164,155 | $1.24 | $203,726 | 2023 Jan 19 |
| Sukhtian Faisal Ghiath | Director | Buy | 30,000 | $1.29 | $38,700 | 2022 Oct 7 |
| Haddadin Yezan Munther | Director | Buy | 33,343 | $1.29 | $42,940 | 2022 Oct 7 |
| Hilzinger Kurt J | Director | Buy | 111,203 | $1.28 | $142,512 | 2022 Oct 5 |
| Hilzinger Kurt J | Director | Buy | 88,797 | $1.24 | $110,500 | 2022 Oct 3 |
| Dagnon Terry | Chief Operating Officer | Buy | 10,000 | $1.05 | $10,500 | 2022 Jun 21 |
| Trenary C Russell III | CEO and President | Buy | 19,925 | $1.06 | $21,121 | 2022 Jun 21 |
Take OTLK further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put OTLK in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Outlook Therapeutics, Inc. next reports.
Set alerts on OTLK
Get notified when Outlook Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free